Viewing Study NCT06182800


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2025-12-26 @ 12:18 PM
Study NCT ID: NCT06182800
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-12-27
First Post: 2023-12-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy
Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module